---
title: "Alvotech, a global biotech company, will announce Q4 and full year 2025 results on March 18, 2026 after US markets close."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277745911.md"
description: "On March 4, 2026, in Reykjavik, Iceland, the biotechnology company Alvotech (NASDAQ: ALVO) shared its plan to unveil the financial and operating outcomes for the fourth quarter and full year 2025 on March 18, 2026. The disclosure will happen post the U.S. markets' closure, showcasing the company's progress in developing and producing biosimilar treatments for global patients."
datetime: "2026-03-04T08:01:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277745911.md)
  - [en](https://longbridge.com/en/news/277745911.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277745911.md)
---

# Alvotech, a global biotech company, will announce Q4 and full year 2025 results on March 18, 2026 after US markets close.

On March 4, 2026, in Reykjavik, Iceland, the biotechnology company Alvotech (NASDAQ: ALVO) shared its plan to unveil the financial and operating outcomes for the fourth quarter and full year 2025 on March 18, 2026. The disclosure will happen post the U.S. markets' closure, showcasing the company's progress in developing and producing biosimilar treatments for global patients.

### Related Stocks

- [ALVO.US](https://longbridge.com/en/quote/ALVO.US.md)
- [ALVOW.US](https://longbridge.com/en/quote/ALVOW.US.md)

## Related News & Research

- [Alvotech Q2 2026 earnings preview](https://longbridge.com/en/news/296273094.md)
- [Alvotech updates financial calendar with H1 2026 results release and webcast Q&A](https://longbridge.com/en/news/295403538.md)
- [Alvotech (ALVO) to Announce Earnings on Wednesday](https://longbridge.com/en/news/295617254.md)
- [Alvotech Q4 And FY25 Revenue Improves, Reaffirms 2026 Guidance](https://longbridge.com/en/news/279777890.md)
- [Alvotech announces successful closure of FDA inspection of manufacturing facility | ALVO Stock News](https://longbridge.com/en/news/294216022.md)